Inherent Biosciences, Inc.

📍 Salt Lake City, United States🗓 Founded 2019👥 12 employees💰 Last funded Nov 2023
Inherent Biosciences is pioneering epigenetic medicine for complex diseases. Gene dysregulation, a hallmark of complex disease, has been difficult to detect and treat, until now... Our epigenetic platform detects dysregulation across multiple genes and related pathways. Were pioneering a new category of diagnostics and therapeutics that leverage epigenetics, biologys inherent mechanism for gene regulation, to radically transform how we diagnose and treat complex diseases like infertility, autoimmune disease, autism, and other complex diseases. Our first products help patients suffering from infertility. See our first product at: pathfertility.com
3
Total investors
0
Early stage
3
Mid stage
0
Late stage
2019
Founded
Investor geography2 countries
United States
2
Canada
1
Frequently asked questions
Who invested in Inherent Biosciences, Inc.?
Inherent Biosciences, Inc. has 3 investors on record on gritt.io, 3 mid-stage.
When did Inherent Biosciences, Inc. last raise funding?
The most recent investment in Inherent Biosciences, Inc. recorded on gritt.io was in November 2023.
When was Inherent Biosciences, Inc. founded?
Inherent Biosciences, Inc. was founded in 2019.
What industry is Inherent Biosciences, Inc. in?
Inherent Biosciences, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Inherent Biosciences, Inc. based?
Inherent Biosciences, Inc. is headquartered in Salt Lake City, United States.